Amur Minerals Corporation Posting of Circular and Notice of General Meeting (1694V)

TIDMAMC

RNS Number : 1694V

Amur Minerals Corporation

08 August 2022

AMUR MINERALS CORPORATION

(AIM: AMC)

Posting of Circular and Notice of General Meeting

Amur Minerals Corporation ("Amur" or the "Company"), the nickel-copper sulphide mineral exploration and resource development company focused on the far east of Russia, announces that a circular ("Circular") and Notice of General Meeting is being posted to Shareholders today. The General Meeting will be held on 24 August 2022 at 10:00 a.m. at the offices of Fieldfisher LLP, Riverbank House, 2 Swan Lane, London EC4R 3TT.

The General Meeting is being convened in relation to the Company's recently announced proposed sale of its wholly owned subsidiary, AO Kun-Manie. A copy of the Circular and Notice of General Meeting is available on the Company's website, https://amurminerals.com/ .

Terms used and not defined in this announcement shall have the same meanings given to them in the Circular.

 
 Company            Nomad and Broker        Public Relations 
  Amur Minerals      S.P. Angel Corporate    BlytheRay 
  Corp.              Finance LLP 
 Robin Young CEO    Richard Morrison        Megan Ray 
                     Adam Cowl               Tim Blythe 
 +44 (0) 7981 126                           +44 (0) 20 7138 
  818               +44 (0) 20 3470 0470     3203

For additional information on the Company, visit the Company's website, www.amurminerals.com .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCKZGGRRNKGZZM

(END) Dow Jones Newswires

August 08, 2022 02:00 ET (06:00 GMT)

Crism Therapeutics (AQSE:AMC.GB)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024